SCHEMBL24916219

SCHEMBL24916219

COc1cc(OC)c2nccc(C(C)C)c2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 4/20 0.41
PDE4D Q08499 2/20 0.41
P2RX3 P56373 2/20 0.40
P2RX2 Q9UBL9 2/20 0.40
NSD2 O96028 1/20 0.39
CASP6 P55212 1/20 0.39
PDE2A O00408 1/20 0.38
PDE3A Q14432 1/20 0.38
PDGFRB P09619 2/20 0.38
PDGFRA P16234 2/20 0.38
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 2/20 0.38
CYP3A4 P08684 2/20 0.38
HPGD P15428 2/20 0.38
HSD17B10 Q99714 2/20 0.38
MEN1 O00255 1/20 0.38
CYP1A2 P05177 1/20 0.38
MAPT P10636 1/20 0.38
ALOX15 P16050 1/20 0.38
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24915646 0.84 P2RX3 (0.37) P2RX3P2RX2KDM4EMEN1MAPT
SCHEMBL24915645 0.84 NSD2 (0.44) PDE10AP2RX3P2RX2NSD2CASP6
SCHEMBL24916430 0.81 NSD2 (0.39) P2RX3P2RX2NSD2CASP6KDM4E
SCHEMBL24916429 0.80 NSD2 (0.39) NSD2CASP6KDM4EALDH1A1MAPT
SCHEMBL24916425 0.80 P2RX3 (0.37) P2RX3P2RX2NSD2CASP6KDM4E
SCHEMBL24916365 0.80 NSD2 (0.39) PDE10AP2RX3P2RX2NSD2CASP6
SCHEMBL10290496 0.79 NSD2 (0.50) PDE10APDE4DNSD2CASP6PDE2A
SCHEMBL24915853 0.79 LMNA (0.50) P2RX3P2RX2KDM4EALDH1A1HPGD
SCHEMBL24392332 0.78 HTR1A (0.56) PDE10AKDM4EALDH1A1HPGDHTR1A
SCHEMBL5262975 0.78 PDGFRB (0.42) PDE10APDE4DNSD2CASP6PDE2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230026466-A1 WDR5 INHIBITORS AND MODULATORS VANDERBILT UNIVERSITY 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230026466-A1 WDR5 INHIBITORS AND MODULATORS WDR5, WDR1, WDR3 PDE10A 3835/4885PDE4D 3925/4885P2RX3 3671/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.